{"id":8487,"date":"2023-11-29T11:53:51","date_gmt":"2023-11-29T09:53:51","guid":{"rendered":"https:\/\/www.easistent.ro\/?p=8487"},"modified":"2023-12-21T13:14:09","modified_gmt":"2023-12-21T11:14:09","slug":"editorial-11","status":"publish","type":"post","link":"https:\/\/www.easistent.ro\/?p=8487","title":{"rendered":"Editorial"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"alignleft size-large is-resized\"><a href=\"https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2023\/11\/poza-mazilu.png\"><img src=\"https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2023\/11\/poza-mazilu-1024x1003.png\" alt=\"\" class=\"wp-image-8447\" width=\"400\" srcset=\"https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2023\/11\/poza-mazilu-1024x1003.png 1024w, https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2023\/11\/poza-mazilu-300x294.png 300w, https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2023\/11\/poza-mazilu-768x753.png 768w, https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2023\/11\/poza-mazilu.png 1148w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure><\/div>\n\n\n\n<p>\u201d<em>Vaccinul HPV este unul dintre cele mai bune, rezistente, cu foarte pu\u021bine reac\u021bii adverse<\/em>\u201d, a declarat recent ministrul S\u0103n\u0103t\u0103\u021bii, Alexandru Rafila, la un eveniment prilejuit de lansarea Ac\u021biunii HPV Rom\u00e2nia<a href=\"#_ftn1\">[1]<\/a>.<\/p>\n\n\n\n<p>Declara\u021bia vine \u00een contextul \u00een care \u201d<em>Rom\u00e2nia dore\u0219te ca s\u0103 ofere acces la tratament, acces la diagnostic precoce \u0219i, bine\u00een\u021beles, la politicile de preven\u021bie<\/em>&#8222;, a mai transmis ministrul S\u0103n\u0103t\u0103\u021bii \u00een cadrul respectivei \u00eent\u00e2lniri.<\/p>\n\n\n\n<p>Pe de alt\u0103 parte, c\u00e2t de eficiente pot fi aceste politici de preven\u021bie ne pot spune studiile bazate pe date din \u021b\u0103rile care, spre deosebire de Rom\u00e2nia (care a e\u0219uat \u00een prima ini\u021biativ\u0103 de a introduce vaccinarea anti-HPV \u00een 2008) au reu\u0219it s\u0103-\u0219i conving\u0103 popula\u021bia de beneficiile vaccin\u0103rii chiar de la momentul apari\u021biei acestui vaccin.<\/p>\n\n\n\n<p>Un astfel de studiu a fost publicat recent de revista STAT<a href=\"#_ftn2\">[2]<\/a> din SUA.<\/p>\n\n\n\n<p>Studiul controlat randomizat a inclus peste 60.000 de femei n\u0103scute \u00een 1992, 1993 \u0219i 1994 din 33 de comunit\u0103\u021bi din Finlanda. El le-a \u00eemp\u0103r\u021bit \u00een mod aleatoriu \u00een trei grupuri, \u00een func\u021bie de strategiile de vaccinare anti &#8211; HPV din comunit\u0103\u021bile lor: vaccinare anti-HPV neutr\u0103 din punct de vedere al genului (unde au fost vaccina\u021bi \u0219i fete \u0219i b\u0103ie\u021bi), vaccinare doar pentru fete \u0219i nicio ac\u021biune de vaccinare. Cercet\u0103torii au urm\u0103rit apoi, la patru \u0219i opt ani dup\u0103 vaccinare, 16 tipuri de HPV genital &#8211; HPV 16\/18\/31\/45, tipuri cu risc oncogen ridicat \u0219i alte 12 tipuri cu risc mai sc\u0103zut de cancer.<\/p>\n\n\n\n<p>Prin acest studiu, cercet\u0103torii au c\u0103utat s\u0103 stabileasc\u0103 cea mai eficient\u0103 strategie de imunizare.<\/p>\n\n\n\n<p>Despre rezultate vorbe\u0219te \u00een articol Ville Pimenoff, cercet\u0103tor principal la Karolinska Institutet \u0219i profesor la Universitatea din Oulu, Finlanda, care a fost autorul principal al studiului. El precizeaz\u0103 c\u0103 studiul demonstreaz\u0103 c\u0103 vaccinul este cel mai eficient atunci c\u00e2nd vaccinezi b\u0103ie\u021bi \u0219i fete: \u201d<em>Putem vedea cum diferitele tipuri de HPV sunt distribuite \u00een comunit\u0103\u021bile \u00een care sunt vaccinate ambele sexe, astfel \u00eenc\u00e2t este clar c\u0103 exist\u0103 o protec\u021bie mai puternic\u0103<\/em>. <em>\u00cen afar\u0103 de vaccinarea individual\u0103, mai apare apoi \u0219i protec\u021bia de turm\u0103<\/em>&#8222;.<\/p>\n\n\n\n<p>\u00cen grupul \u00een care programul de vaccinare din comunitate a inclus \u0219i fetele \u0219i b\u0103ie\u021bii, <strong>o acoperire vaccinal\u0103 de 50% pe an a fost suficient\u0103 pentru a elimina aproape complet tipurile de virus HPV cu risc oncogen ridicat care erau vizate de vaccin<\/strong>. Atunci c\u00e2nd vaccinurile au fost administrate exclusiv fetelor, acoperirea vaccinal\u0103 trebuie s\u0103 fie extrem de ridicat\u0103 (90%) pentru a se ajunge la acelea\u0219i rezultate. Mai mult, reducerea variantei HPV45 a fost observat\u0103 doar \u00een grupul \u00een care programul de vaccinare din comunitate a inclus \u0219i fetele \u0219i b\u0103ie\u021bii.<\/p>\n\n\n\n<p>Dac\u0103 ne uit\u0103m la rezultatele acestui studiu, \u00een \u021b\u0103rile care au o acoperire vaccinal\u0103 bun\u0103, vaccinurile HPV s-au dovedit at\u00e2t de eficiente \u00eenc\u00e2t acolo ar putea fi necesare noi politici de screening, mai pu\u021bin costisitoare financiar pentru \u021b\u0103rile respective.<\/p>\n\n\n\n<p>\u00cen cazul \u00een care screening-ul post-vaccinare se limiteaz\u0103 la tipurile cu risc oncogen ridicat, \u00een \u021b\u0103rile cu acoperire vaccinal\u0103 bun\u0103 cum este Finlanda ar fi suficient s\u0103 se fac\u0103 mai rar, a spus Pimenoff &#8211; poate o dat\u0103 la 10 ani. El a men\u021bionat, totu\u0219i, c\u0103 recomand\u0103rile nu pot fi acelea\u0219i peste tot, deoarece fiecare \u021bar\u0103 are propriul sistem de abordare a vaccin\u0103rii, a screening-ului \u0219i propriile date privind acoperirea vaccinal\u0103.<\/p>\n\n\n\n<p>Cert este c\u0103 rezultatele acestui studiu vorbesc despre efectele benefice pe multiple planuri ale unei politici de succes de sus\u021binere a vaccin\u0103rii anti-HPV \u00een Finlanda, un model la care ne putem uita cu aten\u021bie \u0219i din care s\u0103 \u00eenv\u0103\u021b\u0103m. \u0218i ar fi util s\u0103 facem aceasta pentru a profita \u00een\u021belept de progresele \u0219tiin\u021bei, protej\u00e2ndu-ne popula\u021bia de boli grave prevenibile prin vaccinare precum cancerele asociate virusului HPV.<\/p>\n\n\n\n<p>A\u0219adar, iat\u0103 un model care demonstreaz\u0103 eficien\u021ba unei politici publice \u0219i ne indic\u0103 o direc\u021bie de ac\u021biune&#8230; \u00cen plus de acest subiect de analiz\u0103 \u0219i reflec\u021bie, v\u0103 \u00eencurajez s\u0103 aloca\u021bi timp \u0219i s\u0103 citi\u021bi articolele lunii noiembrie, care prezint\u0103 o serie de teme de actualitate, \u0219i v\u0103 trimit, ca de obicei, cele mai bune g\u00e2nduri.<\/p>\n\n\n\n<p><strong>Doina Carmen Mazilu, Pre\u0219edinte OAMGMAMR \u2013 filiala Bucure\u0219ti<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p><a href=\"#_ftnref1\">[1]<\/a> <a href=\"https:\/\/www.agerpres.ro\/sanatate\/2023\/10\/31\/rafila-vaccinul-anti-hpv-unul-dintre-cele-mai-rezistente-cu-foarte-putine-reactii-adverse--1195795#:~:text=27%20Nr%20afis%C4%83ri-,Rafila%3A%20Vaccinul%20anti%20HPV%20%2D%20unul%20dintre%20cele%20mai%20rezistente%2C,cu%20foarte%20pu%C5%A3ine%20reac%C5%A3ii%20adverse&amp;text=Vaccinul%20anti%20HPV%20este%20unul,lansarea%20ac%C5%A3iunii%20de%20vaccinare%20HP\" target=\"_blank\" rel=\"noreferrer noopener\">Rafila: Vaccinul anti HPV &#8211; unul dintre cele mai rezistente, cu foarte pu\u0163ine reac\u0163ii adverse | AGERPRES \u2022 Actualizeaz\u0103 lumea.<\/a><\/p>\n\n\n\n<p><a href=\"#_ftnref2\">[2]<\/a> <a rel=\"noreferrer noopener\" href=\"https:\/\/www.statnews.com\/2023\/11\/08\/hpv-vaccines-cancer-screenings\" target=\"_blank\">https:\/\/www.statnews.com\/2023\/11\/08\/hpv-vaccines-cancer-screenings<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201dVaccinul HPV este unul dintre cele mai bune, rezistente, cu foarte pu\u021bine reac\u021bii adverse\u201d, a declarat recent ministrul S\u0103n\u0103t\u0103\u021bii, Alexandru Rafila, la un eveniment prilejuit de lansarea Ac\u021biunii HPV Rom\u00e2nia[1]. Declara\u021bia vine \u00een contextul \u00een care \u201dRom\u00e2nia dore\u0219te ca s\u0103 ofere acces la tratament, acces la diagnostic precoce \u0219i, bine\u00een\u021beles, la politicile de preven\u021bie&#8222;, a [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":8447,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[152,54],"tags":[],"_links":{"self":[{"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/posts\/8487"}],"collection":[{"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8487"}],"version-history":[{"count":1,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/posts\/8487\/revisions"}],"predecessor-version":[{"id":8488,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/posts\/8487\/revisions\/8488"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/media\/8447"}],"wp:attachment":[{"href":"https:\/\/www.easistent.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}